Risedronate Sodium (Apotex Corp.)
Welcome to the PulseAid listing for the Risedronate Sodium drug offered from Apotex Corp.. This Bisphosphonate [EPC],Diphosphonates [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Apotex Corp. |
NON-PROPRIETARY NAME: | Risedronate Sodium |
SUBSTANCE NAME: | RISEDRONATE SODIUM |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Bisphosphonate [EPC],Diphosphonates [Chemical/Ingredient] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET, FILM COATED |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2014-06-11 |
END MARKETING DATE: | 0000-00-00 |
Risedronate Sodium HUMAN PRESCRIPTION DRUG Details:
Item Description | Risedronate Sodium from Apotex Corp. |
LABELER NAME: | Apotex Corp. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 75(mg/1) |
START MARKETING DATE: | 2014-06-11 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 60505-3096_1da1085d-93a4-d093-60fc-500db3d70cea |
PRODUCT NDC: | 60505-3096 |
APPLICATION NUMBER: | ANDA090877 |
Other RISEDRONATE SODIUM Pharmaceutical Manufacturers / Labelers: